Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for B5950S113 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Laurence W. Lytton
13G/A
|
19.5% |
8/17/2026
Event 8/13/2026
|
||
| Laurence W. Lytton | 19.5% | |||
| Lytton-Kambara Foundation | 12.1% | |||
|
Exact Sciences Corp
13G/A
|
12.0% |
1/16/2026
Event 1/9/2026
|
||
| Genomic Health, Inc. | 12.0% | |||
| Exact Sciences Corporation | 12.0% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||
| AWM Investment Company, Inc. 13G/A | 0% |
7/8/2026
Event 6/30/2026
|
||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 3 | 32.1 k | $18.8 k |
| 2026 Q2 | 27 | 16.6 M | $6.80 M |
| 2026 Q1 | 52 | 24.7 M | $56.9 M |
| 2025 Q4 | 56 | 24.3 M | $86.8 M |
| 2025 Q3 | 41 | 22.7 M | $106 M |
| 2025 Q2 | 22 | 21.5 M | $47.6 M |
| 2025 Q1 | 22 | 21.2 M | $30.1 M |
| 2024 Q4 | 25 | 22.5 M | $53.2 M |
| 2024 Q3 | 23 | 22.8 M | $47.4 M |
| 2024 Q2 | 11 | 8.95 M | $21.0 M |
| 2024 Q1 | 16 | 9.36 M | $24.2 M |
| 2023 Q4 | 13 | 9.60 M | $37.6 M |